209 related articles for article (PubMed ID: 31908796)
1. Spatial variations in gut permeability are linked to type 1 diabetes development in non-obese diabetic mice.
Joesten WC; Short AH; Kennedy MA
BMJ Open Diabetes Res Care; 2019; 7(1):e000793. PubMed ID: 31908796
[TBL] [Abstract][Full Text] [Related]
2. Ameliorating gut microenvironment through staphylococcal nuclease-mediated intestinal NETs degradation for prevention of type 1 diabetes in NOD mice.
Liang Y; Wang X; He D; You Q; Zhang T; Dong W; Fei J; Xing Y; Wu J
Life Sci; 2019 Mar; 221():301-310. PubMed ID: 30776371
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
Front Immunol; 2019; 10():1733. PubMed ID: 31417546
[TBL] [Abstract][Full Text] [Related]
4. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats.
Watts T; Berti I; Sapone A; Gerarduzzi T; Not T; Zielke R; Fasano A
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2916-21. PubMed ID: 15710870
[TBL] [Abstract][Full Text] [Related]
5. Frontline Science: Abnormalities in the gut mucosa of non-obese diabetic mice precede the onset of type 1 diabetes.
Miranda MCG; Oliveira RP; Torres L; Aguiar SLF; Pinheiro-Rosa N; Lemos L; Guimarães MA; Reis D; Silveira T; Ferreira Ê; Moreira TG; Cara DC; Maioli TU; Kelsall BL; Carlos D; Faria AMC
J Leukoc Biol; 2019 Sep; 106(3):513-529. PubMed ID: 31313381
[TBL] [Abstract][Full Text] [Related]
6. Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice.
Simon MC; Reinbeck AL; Wessel C; Heindirk J; Jelenik T; Kaul K; Arreguin-Cano J; Strom A; Blaut M; Bäckhed F; Burkart V; Roden M
J Biol Chem; 2020 Jan; 295(4):969-980. PubMed ID: 31822562
[TBL] [Abstract][Full Text] [Related]
7. Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice.
Krych Ł; Nielsen DS; Hansen AK; Hansen CH
Gut Microbes; 2015; 6(2):101-9. PubMed ID: 25648687
[TBL] [Abstract][Full Text] [Related]
8. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
[TBL] [Abstract][Full Text] [Related]
9. Incretin hormone expression in the gut of diabetic mice and rats.
Berghöfer P; Peterson RG; Schneider K; Fehmann HC; Göke B
Metabolism; 1997 Mar; 46(3):261-7. PubMed ID: 9054467
[TBL] [Abstract][Full Text] [Related]
10. Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity.
Wood Heickman LK; DeBoer MD; Fasano A
Diabetes Metab Res Rev; 2020 Jul; 36(5):e3309. PubMed ID: 32162764
[TBL] [Abstract][Full Text] [Related]
11. Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.
Tanca A; Palomba A; Fraumene C; Manghina V; Silverman M; Uzzau S
mSphere; 2018 Oct; 3(5):. PubMed ID: 30355671
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice.
Shen Y; You Q; Wu Y; Wu J
Eur J Pharmacol; 2022 Feb; 916():174623. PubMed ID: 34767782
[TBL] [Abstract][Full Text] [Related]
13. Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model.
Sturgeon C; Lan J; Fasano A
Ann N Y Acad Sci; 2017 Jun; 1397(1):130-142. PubMed ID: 28423466
[TBL] [Abstract][Full Text] [Related]
14. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives.
Sapone A; de Magistris L; Pietzak M; Clemente MG; Tripathi A; Cucca F; Lampis R; Kryszak D; Cartenì M; Generoso M; Iafusco D; Prisco F; Laghi F; Riegler G; Carratu R; Counts D; Fasano A
Diabetes; 2006 May; 55(5):1443-9. PubMed ID: 16644703
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma zonulin in patients with sepsis.
Klaus DA; Motal MC; Burger-Klepp U; Marschalek C; Schmidt EM; Lebherz-Eichinger D; Krenn CG; Roth GA
Biochem Med (Zagreb); 2013; 23(1):107-11. PubMed ID: 23457771
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of Autoimmune Diabetes of NOD Mice by Immunomodulating Probiotics.
Kim TK; Lee JC; Im SH; Lee MS
Front Immunol; 2020; 11():1832. PubMed ID: 33013834
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse.
Hadjiyanni I; Li KK; Drucker DJ
Endocrinology; 2009 Feb; 150(2):592-9. PubMed ID: 18845625
[TBL] [Abstract][Full Text] [Related]
18. Effect of diabetic state on co-localization of substance P and serotonin in the gut in animal models.
Spångéus A; Forsgren S; El-Salhy M
Histol Histopathol; 2001 Apr; 16(2):393-8. PubMed ID: 11332694
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for assessment of intestinal permeability in clinical practice.
Seethaler B; Basrai M; Neyrinck AM; Nazare JA; Walter J; Delzenne NM; Bischoff SC
Am J Physiol Gastrointest Liver Physiol; 2021 Jul; 321(1):G11-G17. PubMed ID: 34009040
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota from B-cell-specific TLR9-deficient NOD mice promote IL-10
Yang X; Huang J; Peng J; Wang P; Wong FS; Wang R; Wang D; Wen L
Front Immunol; 2024; 15():1413177. PubMed ID: 38903498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
